NO145074C - Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzazepinderivater - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzazepinderivater

Info

Publication number
NO145074C
NO145074C NO75754126A NO754126A NO145074C NO 145074 C NO145074 C NO 145074C NO 75754126 A NO75754126 A NO 75754126A NO 754126 A NO754126 A NO 754126A NO 145074 C NO145074 C NO 145074C
Authority
NO
Norway
Prior art keywords
preparation
therapeutic active
analogy procedure
dibenzazepine derivatives
dibenzazepine
Prior art date
Application number
NO75754126A
Other languages
English (en)
Norwegian (no)
Other versions
NO754126L (OSRAM
NO145074B (no
Inventor
Yoshinori Takashima
Isamu Maruyama
Junki Katsube
Original Assignee
Sumitomo Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP14169174A external-priority patent/JPS5833875B2/ja
Priority claimed from JP291175A external-priority patent/JPS5939433B2/ja
Priority claimed from JP4989175A external-priority patent/JPS5939435B2/ja
Application filed by Sumitomo Chemical Co filed Critical Sumitomo Chemical Co
Publication of NO754126L publication Critical patent/NO754126L/no
Publication of NO145074B publication Critical patent/NO145074B/no
Publication of NO145074C publication Critical patent/NO145074C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/26—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a double bond between positions 10 and 11
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
    • C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
    • C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
    • C07D223/28—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
NO75754126A 1974-12-09 1975-12-08 Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzazepinderivater NO145074C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP14169174A JPS5833875B2 (ja) 1974-12-09 1974-12-09 シンキナルモルホリンユウドウタイ オヨビ ソノサンフカエンノセイゾウホウ
JP291175A JPS5939433B2 (ja) 1974-12-27 1974-12-27 新規なるモルホリン誘導体及びその酸付加塩の製造法
JP4989175A JPS5939435B2 (ja) 1975-04-23 1975-04-23 新規なるモルホリン誘導体及びその酸付加塩の製造法

Publications (3)

Publication Number Publication Date
NO754126L NO754126L (OSRAM) 1976-06-10
NO145074B NO145074B (no) 1981-09-28
NO145074C true NO145074C (no) 1982-01-06

Family

ID=27275587

Family Applications (1)

Application Number Title Priority Date Filing Date
NO75754126A NO145074C (no) 1974-12-09 1975-12-08 Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzazepinderivater

Country Status (15)

Country Link
US (1) US4017621A (OSRAM)
AR (2) AR213082A1 (OSRAM)
AT (1) AT348532B (OSRAM)
CA (1) CA1064924A (OSRAM)
CH (2) CH622792A5 (OSRAM)
DE (1) DE2555351A1 (OSRAM)
DK (1) DK551175A (OSRAM)
ES (1) ES443333A1 (OSRAM)
FI (1) FI753414A7 (OSRAM)
FR (1) FR2293936A1 (OSRAM)
GB (1) GB1510669A (OSRAM)
HU (1) HU170641B (OSRAM)
NL (1) NL7514348A (OSRAM)
NO (1) NO145074C (OSRAM)
SE (1) SE419985B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW248556B (OSRAM) * 1993-01-18 1995-06-01 Takeda Pharm Industry Co
US6214816B1 (en) * 1998-03-17 2001-04-10 Novo Nordisk A/S Heterocyclic compounds
JP2002506863A (ja) * 1998-03-17 2002-03-05 ノボ ノルディスク アクティーゼルスカブ 新規ヘテロ環式化合物
TWI435729B (zh) 2005-11-09 2014-05-01 Combinatorx Inc 治療病症之方法，組合物及套組

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2976281A (en) * 1961-03-21 Substituted iminostilbenes
NL110232C (OSRAM) * 1958-12-06
CH554342A (de) * 1969-06-20 1974-09-30 Takeda Chemical Industries Ltd Verfahren zur herstellung neuer dibenzazepinderivate.

Also Published As

Publication number Publication date
CH626083A5 (OSRAM) 1981-10-30
NL7514348A (nl) 1976-06-11
SE7513577L (sv) 1976-06-10
CA1064924A (en) 1979-10-23
SE419985B (sv) 1981-09-07
DE2555351A1 (de) 1976-06-10
FR2293936A1 (fr) 1976-07-09
HU170641B (OSRAM) 1977-07-28
ATA931175A (de) 1978-07-15
NO754126L (OSRAM) 1976-06-10
CH622792A5 (OSRAM) 1981-04-30
ES443333A1 (es) 1978-02-01
AR213082A1 (es) 1978-12-15
US4017621A (en) 1977-04-12
FR2293936B1 (OSRAM) 1978-11-10
GB1510669A (en) 1978-05-10
AT348532B (de) 1979-02-26
DK551175A (da) 1976-06-10
NO145074B (no) 1981-09-28
AU8734175A (en) 1977-06-16
AR212970A1 (es) 1978-11-30
FI753414A7 (OSRAM) 1976-06-10

Similar Documents

Publication Publication Date Title
NO143576C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heterocykliske forbindelser
NO147243C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ftalanderivater
NO149106C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzcykloamider
NO141407C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive etylenderivater
NO151411C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-aryloksy-2-hydroksy-3-alkylenaminopropan-derivater
NO147450C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinazolonderivater
NO141800C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO143460C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner.
NO148453C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive spirohydantoinderivater
NO143575C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive prostansyre-derivater
NO145056C (no) (s)-1-aryloksy-2-propanolderivater for fremstilling av terapeutisk aktive (s)-1-aryloksy-3-amino-2-propanolderivater
NO142838C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive isokinolinderivater
NO141894C (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive pyridobenzodiazepinoner
NO143064C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive hydroksyalkylxantiner
NO148291C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive basisk substituerte teofyllinderivater
NO148488C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive acyl-benzimidazol-2-derivater
NO144108C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive n-(1-benzylpiperid-4-yl)-benzamider
NO145238C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydrokarbostyril-derivater
NO147485C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 8-aminomethylisoflavonderivater
NO146672C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cinnolinderivater
NO144704C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive 1-alkyl-2-(fenoksymetyl)-5-nitro-imidazoler
NO144110C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 5:6-benzo-4-pyron-derivater
NO143903C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-fluorpyrimidin-4-on-derivater
SE414028B (sv) Forfarande for framstellning av terapeutisk verksamma fentiazinderivat
NO145074C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dibenzazepinderivater